Literature DB >> 16355089

Comparison of two intermittent pneumatic compression systems. A hemodynamic study.

S K Kakkos1, A N Nicolaides, M Griffin, G Geroulakos.   

Abstract

AIM: Sequential leg compression has been previously shown to be superior to uniform compression. The aim of our study was to compare the hemodynamic effectiveness of the portable sequential compression device (SCD Express Compression System, Tyco Healthcare Group LP, Mansfield, MA, USA) with a rapid inflation device (VenaFlow, Aircast, Inc, Summit, NJ, USA). The former, by sensing venous refill time, commences compression when the calf veins are refilled.
METHODS: The two devices were tested in 12 normal volunteers in the semirecumbent position using duplex ultrasound. Baseline and augmented flow velocity and volume flow were measured at the level of the common femoral vein, above the saphenofemoral junction. Refilling time was determined from velocity recordings of the common femoral vein. Total and peak volume of blood expelled per hour during compression were calculated using flow data and the individual cycling rate.
RESULTS: Both devices increased venous flow velocity, up to 3.8 times the baseline (all P<0.001). Refill time of the rapid inflation device was shorter in comparison with the sequential compression device (15+/-2.2 vs 25+/-4 s; P<0.001), suggesting incomplete vein evacuation. The sequential compression device, by augmenting flow throughout a significantly longer compression period per cycle (10.9 s vs 6.3 s), expelled significantly more venous blood (121+/-68 vs 81+/-63 mL; P<0.001). Similarly, the total volume of blood expelled per hour with the sequential compression device was 100% higher than the rapid inflation device (9685+/-5426 vs 4853+/-3658 mL; P<0.001). Although peak velocity enhancement was higher with the rapid inflation device, flow augmentation (a product of average blood flow velocity) was comparable (669+/-367 vs 771+/-574 cm/s; P=0.223) with the sequential compression device, mainly because the rapid inflation device failed to maintain flow enhancement beyond the initial flow surge.
CONCLUSIONS: Sequential compression showed hemodynamic superiority compared to a rapid inflation device. This was enhanced further by the sensing of refill time, which resulted in more compression cycles over time. The relative efficacy of the two devices in deep vein thrombosis prevention should be tested in future studies.

Entities:  

Mesh:

Year:  2005        PMID: 16355089

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  5 in total

Review 1.  [S1 guideline on intermittent pneumatic compression (IPC)].

Authors:  C Schwahn-Schreiber; F X Breu; E Rabe; I Buschmann; W Döller; G R Lulay; A Miller; E Valesky; S Reich-Schupke
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

2.  What influence does intermittent pneumatic compression of the lower limbs intraoperatively have on core hypothermia?

Authors:  Jin Huh; Yong-Beom Cho; Mi-Kyung Yang; Yeon-Kyeong Yoo; Duk-Kyung Kim
Journal:  Surg Endosc       Date:  2013-01-09       Impact factor: 4.584

3.  Acute oxygenation changes on ischemic foot of a novel intermittent pneumatic compression device and of an existing sequential device in severe peripheral arterial disease.

Authors:  Fabio Manfredini; Anna Maria Malagoni; Michele Felisatti; Simona Mandini; Nicola Lamberti; Roberto Manfredini; Francesco Mascoli; Nino Basaglia; Paolo Zamboni
Journal:  BMC Cardiovasc Disord       Date:  2014-03-31       Impact factor: 2.298

4.  Effect of sequential pneumatic compression therapy on venous blood velocity, refilling time, pain and quality of life in women with varicose veins: a randomized control study.

Authors:  Abeer Yamany; Bassant Hamdy
Journal:  J Phys Ther Sci       Date:  2016-07-29

5.  Mechanical prophylaxis for venous thromboembolism prevention in obese individuals.

Authors:  Amulya Khatri; Alun H Davies; Joseph Shalhoub
Journal:  Phlebology       Date:  2021-07-06       Impact factor: 1.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.